z-logo
open-access-imgOpen Access
Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis
Author(s) -
HsinYun Sun,
Barbara D. Alexander,
Olivier Lortholary,
Françoise Dromer,
Graeme N. Forrest,
G. Marshall Lyon,
Jyoti Somani,
Krishan Lal Gupta,
Ramon Del Busto,
Timothy L. Pruett,
Costi D. Sifri,
Ajit P. Limaye,
George John,
Göran B. Klintmalm,
Kenneth Pursell,
Valentina Stosor,
Michelle I. Morris,
Lorraine A. Dowdy,
Patricia Muñóz,
André C. Kalil,
Julia GarciaDiaz,
Susan L. Orloff,
Andrew A. House,
Sally Houston,
Dannah Wray,
Shirish Huprikar,
Leonard B. Johnson,
Atul Humar,
Raymund R. Razonable,
Shahid Husain,
Nina Singh
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/647948
Subject(s) - amphotericin b , medicine , fungemia , amphotericin b deoxycholate , odds ratio , gastroenterology , univariate analysis , antifungal drug , cryptococcosis , confidence interval , surgery , mycosis , immunology , antifungal , multivariate analysis , caspofungin , dermatology
Whether outcome of central nervous system (CNS) cryptococcosis in solid organ transplant recipients treated with lipid formulations of amphotericin B is different from the outcome of the condition treated with amphotericin B deoxycholate (AmBd) is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom